The human immune response to Mycobacterium tuberculosis in lung and lymph node

Journal of Theoretical Biology

Volumn 227, Issue 4, 2004, Pages 463-486

  Marino, Simeone ^a   Kirschner, Denise E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Dendritic cells; Human; Lung and lymph nodes; M. tuberculosis; Model

Indexed keywords

CYTOKINE;

BIOLOGY; IMMUNE RESPONSE; TUBERCULOSIS;

ARTICLE; CELL ACTIVATION; CELLULAR IMMUNITY; COMPARTMENT MODEL; HUMAN; IMMUNE RESPONSE; LUNG INFECTION; LYMPH NODE; MATHEMATICAL MODEL; MYCOBACTERIUM TUBERCULOSIS; PREDICTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TUBERCULOSIS;

CYTOKINES; DENDRITIC CELLS; DISEASE PROGRESSION; HUMANS; IMMUNITY; LUNG; LYMPH NODES; LYMPHOCYTES; MATHEMATICS; MODELS, IMMUNOLOGICAL; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 1642407734     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtbi.2003.11.023     Document Type: Article

References (158)

1. Abu-Amero K. Tuberculosis information on the web. J. R. Soc. Health. 122(2):2002;82.
2. Allen J.E., Maizels R.M. Th1-Th2. reliable paradigm or dangerous dogma? Immunol Today. 18(8):1997;387.
3. Annunziato F., Galli G., Cosmi L., Romagnani P., Manetti R., Maggi E., Romagnani S. Molecules associated with human Th1 or Th2 cells. Eur. Cytokine Network. 9(3 Suppl):1998;12.
4. Antony V.B., Godbey S.W., Kunkel S.L., Hott J.W., Hartman D.L., Burdick M.D., Strieter R.M. Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. J. Immunol. 151(12):1993;7216.
5. Appelberg R., Orme I.M., Pinto de Sousa M.I., Silva M.T. In vitro effects of interleukin-4 on interferon-gamma-induced macrophage activation. Immunology. 76(4):1992;553.
6. Arend S.M., van Dissel J.T. Evidence of endogenous reactivation of tuberculosis after a long period of latency. J. Infect. Dis. 186(6):2002;876.
7. Assenmacher M., Lohning M., Scheffold A., Richter A., Miltenyi S., Schmitz J., Radbruch A. Commitment of individual Th1-like lymphocytes to expression of IFN-gamma versus IL-4 and IL-10. selective induction of IL-10 by sequential stimulation of naive Th cells with IL-12 and IL-4 J. Immunol. 161(6):1998;2825.
8. Balcewicz-Sablinska M.K., Keane J., Kornfeld H., Remold H.G. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J. Immunol. 161(5):1998;2636.
9. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392(6673):1998;245.
10. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:2000;767.
11. Barnes P.F., Lu S., Abrams J.S., Wang E., Yamamura M., Modlin R.L. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61(8):1993;3482.
12. Bellamy R., Ruwende C., Corrah T., McAdam K.P., Whittle H.C., Hill A.V. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med. 338(10):1998;640.
13. Bellamy R., Ruwende C., Corrah T., McAdam K.P., Thursz M., Whittle H.C., Hill A.V. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J. Infect. Dis. 179(3):1999;721.
14. Bhattacharyya S., Singla R., Dey A.B., Prasad H.K. Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis. Infect. Immun. 67(11):1999;5597.
15. Bloom B.R. Tuberculosis. Pathogenesis, Protection, and Control:1994;ASM Press, Washington, DC.
16. Blower S.M., Dowlatabadi H. Sensitivity and uncertainty analysis of complex-models of disease transmission - an HIV model, as an example. Int. Stat. Rev. 62(2):1994;229.
17. Bodnar K.A., Serbina N.V., Flynn J.L. Fate of Mycobacterium tuberculosis within murine dendritic cells. Infect. Immun. 69(2):2001;800.
18. Bottomly K. T cells and dendritic cells get intimate. Science. 283(5405):1999;1124.
19. Capuano S.V. III, Croix D.A., Pawar S., Zinovik A., Myers A., Lin P.L., Bissel S., Fuhrman C., Klein E., Flynn J.L. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect. Immun. 71:2003;5831-5844.
20. Caruso A.M., Serbina N., Klein E., Triebold K., Bloom B.R., Flynn J.L. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J. Immunol. 162(9):1999;5407.
21. Chensue S.W., Ruth J.H., Warmington K., Lincoln P., Kunkel S.L. In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation. J. Immunol. 155(7):1995;3546.
22. Choi M.S., Lee J.H., Koh K.C., Paik S.W., Rhee P.L., Kim J.J., Rhee J.C., Choi K.W., Kim S.H. Clinical significance of enlarged perihepatic lymph nodes in chronic hepatitis B. J. Clin. Gastroenterol. 32(4):2001;329.
23. Chomarat P., Rissoan M.C., Banchereau J., Miossec P. Interferon gamma inhibits interleukin 10 production by monocytes. J. Exp. Med. 177(2):1993;523.
24. Comstock G.W., Livesay V.T., Woolpert S.F. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am. J. Epidemiol. 99(2):1974;131.
25. Condos R., Rom W.N., Liu Y.M., Schluger N.W. Local immune responses correlate with presentation and outcome in tuberculosis. Am. J. Respir. Crit. Care. Med. 157(3 Pt 1):1998;729.
26. Cooper A.M., Dalton D.K., Stewart T.A., Griffin J.P., Russell D.G., Orme I.M. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178(6):1993;2243.
27. Cooper A.M., Magram J., Ferrante J., Orme I.M. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186(1):1997;39.
28. Crowle A.J., Elkins N. Relative permissiveness of macrophages from black and white people for virulent tubercle bacilli. Infect. Immun. 58(3):1990;632.
29. D'Andrea A., Aste-Amezaga M., Valiante N.M., Ma X., Kubin M., Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178(3):1993;1041.
30. Demangel C., Britton W.J. Interaction of dendritic cells with mycobacteria. where the action starts Immunol. Cell Biol. 78(4):2000;318.
31. DesJardin L.E., Kaufman T.M., Potts B., Kutzbach B., Yi H., Schlesinger L.S. Mycobacterium tuberculosis-infected human macrophages exhibit enhanced cellular adhesion with increased expression of LFA-1 and ICAM-1 and reduced expression and/or function of complement receptors, FcgammaRII and the mannose receptor. Microbiology. 148(Pt 10):2002;3161.
32. de Waal Malefyt R., Figdor C.G., de Vries J.E. Effects of interleukin 4 on monocyte functions. comparison to interleukin 13 Res. Immunol. 144(8):1993;629.
33. Dlugovitzky D., Bay M.L., Rateni L., Urizar L., Rondelli C.F., Largacha C., Farroni M.A., Molteni O., Bottasso O.A. In vitro synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin-1 beta by peripheral blood mononuclear cells from tuberculosis patients. relationship with the severity of pulmonary involvement Scand. J. Immunol. 49(2):1999;210.
34. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Consensus statement. Global burden of tuberculosis. estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project J. Am. Med. Assoc. 282(7):1999;677.
35. Feng C.G., Demangel C., Kamath A.T., Macdonald M., Britton W.J. Dendritic cells infected with Mycobacterium bovis bacillus Calmette Guerin activate CD8(+) T cells with specificity for a novel mycobacterial epitope. Int. Immunol. 13(4):2001;451.
36. Fenhalls G., Stevens L., Moses L., Bezuidenhout J., Betts J.C., Helden Pv.P., Lukey P.T., Duncan K. In situ detection of Mycobacterium tuberculosis transcripts in human lung granulomas reveals differential gene expression in necrotic lesions. Infect. Immun. 70(11):2002;6330.
37. Flesch I.E., Kaufmann S.H. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect. Immun. 58(8):1990;2675.
38. Flynn J.L., Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 19:2001;93.
39. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178(6):1993;2249.
40. Fortsch D., Rollinghoff M., Stenger S. IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J. Immunol. 165(2):2000;978.
41. Fulton S.A., Johnsen J.M., Wolf S.F., Sieburth D.S., Boom W.H. Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis. role of phagocytosis Infect. Immun. 64(7):1996;2523.
42. Fulton S.A., Cross J.V., Toossi Z.T., Boom W.H. Regulation of interleukin-12 by interleukin-10, transforming growth factor-beta, tumor necrosis factor-alpha, and interferon-gamma in human monocytes infected with Mycobacterium tuberculosis H37Ra. J. Infect. Dis. 178(4):1998;1105.
43. Gammack, D., C.R. Doering and D.E. Kirschner, 2003. Macrophage response to Mycobacterium tuberculosis infection, J. Math. Biol. Published online: 20 August 2003, (to appear) Feb 2004.
44. Giacomini E., Iona E., Ferroni L., Miettinen M., Fattorini L., Orefici G., Julkunen I., Coccia E.M. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J. Immunol. 166(12):2001;7033.
45. Gonzalez-Juarrero M., Orme I.M. Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis. Infect. Immun. 69(2):2001;1127.
46. Greenland S. Sensitivity analysis, Monte Carlo risk analysis, and Bayesian uncertainty assessment. Risk. Anal. 21(4):2001;579.
47. Guermonprez P., Valladeau J., Zitvogel L., Thery C., Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:2002;621.
48. Havenith C.E., Breedijk A.J., Hoefsmit E.C. Effect of bacillus Calmette-Guerin inoculation on numbers of dendritic cells in bronchoalveolar lavages of rats. Immunobiology. 184(4-5):1992;336.
49. Helton J.C., Davis F.J. Illustration of sampling-based methods for uncertainty and sensitivity analysis. Risk Anal. 22(3):2002;591.
50. Henderson R.A., Watkins S.C., Flynn J.L. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 159(2):1997;635.
51. Hernandez-Pando R., Rook G.A. The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance. Immunology. 82(4):1994;591.
52. Hickman S.P., Chan J., Salgame P. Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with divergent effects on naive T cell polarization. J. Immunol. 168(9):2002;4636.
53. Hirsch C.S., Yoneda T., Averill L., Ellner J.J., Toossi Z. Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1. J. Infect. Dis. 170(5):1994;1229.
54. Holt, P.G., 2000. Antigen presentation in the lung. Am. J. Respir. Crit. Care Med. 162 (4 Pt 2), S151. #6.
55. Holt P.G., Schon-Hegrad M.A. Localization of T cells, macrophages and dendritic cells in rat respiratory tract tissue. implications for immune function studies Immunology. 62(3):1987;349.
56. Holt, P.G., Stumbles, P.A., 2000a. Characterization of dendritic cell populations in the respiratory tract. J. Aerosol. Med. 13 (4), 361. #8.
57. Holt, P.G., Stumbles, P.A., 2000b. Regulation of immunologic homeostasis in peripheral tissues by dendritic cells: the respiratory tract as a paradigm. J. Allergy Clin. Immunol. 105 (3), 421. #9.
58. Holt P.G., Oliver J., Bilyk N., McMenamin C., McMenamin P.G., Kraal G., Thepen T. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J. Exp. Med. 177(2):1993;397.
59. Huhn R.D., Radwanski E., O'Connell S.M., Sturgill M.G., Clarke L., Cody R.P., Affrime M.B., Cutler D.L. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood. 87(2):1996;699.
60. Huhn R.D., Radwanski E., Gallo J., Affrime M.B., Sabo R., Gonyo G., Monge A., Cutler D.L. Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers. Clin. Pharmacol. Ther. 62(2):1997;171.
61. Iseman, M.D., 1999a. International Union against Tuberculosis and Lung Disease. World Conference. Update treatment of multidrug-resistant tuberculosis: Proceedings of a sponsored symposium to the 29th World Conference of the International Union against Tuberculosis and Lung Diseases (IUATLD/UICTMR), Bangkok, Thailand, November 24, 1998. S. Karger, Basel, New York.
62. Iseman M.D. Treatment and implications of multidrug-resistant tuberculosis for the 21st century. Chemotherapy. 45:1999;34-40.
63. Iseman M.D. Tuberculosis therapy. past, present and future Eur. Respir. J. Suppl. 36:2002;87s-94s.
64. Isler P., de Rochemonteix B.G., Songeon F., Boehringer N., Nicod L.P. Interleukin-12 production by human alveolar macrophages is controlled by the autocrine production of interleukin-10. Am. J. Respir. Cell. Mol. Biol. 20(2):1999;270.
65. Janeway, C., 2001. Immunobiology 5: The Immune System in Health and Disease. Garland Pub., New York. #201.
66. Jiao X., Lo-Man R., Guermonprez P., Fiette L., Deriaud E., Burgaud S., Gicquel B., Winter N., Leclerc C. Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J. Immunol. 168(3):2002;1294.
67. Jung Y.J., LaCourse R., Ryan L., North R.J. Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice. Infect. Immun. 70(11):2002;6436.
68. Keane J., Remold H.G., Kornfeld H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J. Immunol. 164(4):2000;2016.
69. Kirschner D. Dynamics of co-infection with M. Tuberculosis and HIV-1. Theor. Popul. Biol. 55:1999;94-109.
70. Klopfens Rw. Numerical Differentiation Formulas for Stiff Systems of Ordinary Differential Equations. Rca Rev. 32(3):1971;447.
71. Kurzrock R., Rosenblum M.G., Sherwin S.A., Rios A., Talpaz M., Quesada J.R., Gutterman J.U. Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients. Cancer Res. 45(6):1985;2866.
72. Lai C.K., Ho S., Chan C.H., Chan J., Choy D., Leung R., Lai K.N. Cytokine gene expression profile of circulating CD4+ T cells in active pulmonary tuberculosis. Chest. 111(3):1997;606.
73. Lalvani A., Brookes R., Wilkinson R.J., Malin A.S., Pathan A.A., Andersen P., Dockrell H., Pasvol G., Hill A.V. Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA. 95(1):1998;270.
74. Langenkamp A., Messi M., Lanzavecchia A., Sallusto F. Kinetics of dendritic cell activation. impact on priming of TH1, TH2 and nonpolarized T cells Nat. Immunol. 1(4):2000;311.
75. Langermans J.A., Andersen P., van Soolingen D., Vervenne R.A., Frost P.A., van der Laan T., van Pinxteren L.A., van den Hombergh J., Kroon S., Peekel I., Florquin S., Thomas A.W. Divergent effect of bacillus Calmette-Guerin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species. implications for primate models in tuberculosis vaccine research Proc. Natl Acad. Sci. USA. 98(20):2001;11497.
76. Lanzavecchia A., Sallusto F. Dynamics of T lymphocyte responses. intermediates, effectors, and memory cells Science. 290(5489):2000;92.
77. Lanzavecchia, A., Sallusto, F., 2001a. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr. Opin. Immunol. 13 (3), 291. #122.
78. Lanzavecchia, A., Sallusto, F., 2001b. Regulation of T cell immunity by dendritic cells. Cell 106 (3), 263. #123.
79. Law K., Weiden M., Harkin T., Tchou-Wong K., Chi C., Rom W.N. Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 153(2):1996;799.
80. Lazarevic V., Flynn J. CD8(+) T cells in tuberculosis. Am. J. Respir. Crit. Care Med. 166(8):2002;1116.
81. Lewinsohn D.M., Bement T.T., Xu J., Lynch D.H., Grabstein K.H., Reed S.G., Alderson M.R. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms. J. Immunol. 160(5):1998;2374.
82. Lillebaek T., Dirksen A., Baess I., Strunge B., Thomsen V.O., Andersen A.B. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J. Infect. Dis. 185(3):2002;401.
83. Lin Y., Zhang M., Hofman F.M., Gong J., Barnes P.F. Absence of a prominent Th2 cytokine response in human tuberculosis. Infect. Immun. 64(4):1996;1351.
84. Lin C.L., Sewell A.K., Gao G.F., Whelan K.T., Phillips R.E., Austyn J.M. Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis. J. Exp. Med. 192(4):2000;587.
85. Lucey D.R., Clerici M., Shearer G.M. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin. Microbiol. Rev. 9(4):1996;532.
86. Maggi E., Parronchi P., Manetti R., Simonelli C., Piccinni M.P., Rugiu F.S., De Carli M., Ricci M., Romagnani S. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J. Immunol. 148(7):1992;2142.
87. Manca C., Tsenova L., Barry C.E. III, Bergtold A., Freeman S., Haslett P.A., Musser J.M., Freedman V.H., Kaplan G. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J. Immunol. 162(11):1999;6740.
88. Manetti R., Parronchi P., Giudizi M.G., Piccinni M.P., Maggi E., Trinchieri G., Romagnani S. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177(4):1993;1199.
89. McDonough K.A., Kress Y., Bloom B.R. Pathogenesis of tuberculosis. interaction of Mycobacterium tuberculosis with macrophages Infect. Immun. 61(7):1993;2763.
90. Mercer R.R., Russell M.L., Roggli V.L., Crapo J.D. Cell number and distribution in human and rat airways. Am. J. Respir. Cell Mol. Biol. 10(6):1994;613.
91. Meyaard L., Hovenkamp E., Otto S.A., Miedema F. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J. Immunol. 156(8):1996;2776.
92. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:2001;683.
93. Nathan C.F., Murray H.W., Wiebe M.E., Rubin B.Y. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158(3):1983;670.
94. Newport M.J., Huxley C.M., Huston S., Hawrylowicz C.M., Oostra B.A., Williamson R., Levin M. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335(26):1996;1941.
95. North R.J. Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin. Exp. Immunol. 113(1):1998;55.
96. North R.J., Izzo A.A. Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity. J. Exp. Med. 177(6):1993;1723.
97. Oddo M., Renno T., Attinger A., Bakker T., MacDonald H.R., Meylan P.R. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J. Immunol. 160(11):1998;5448.
98. O'Donnell M.A., Luo Y., Chen X., Szilvasi A., Hunter S.E., Clinton S.K. Role of IL-12 in the induction and potentiation of IFN-gamma in response to bacillus Calmette-Guerin. J. Immunol. 163(8):1999;4246.
99. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8(3):1998;275.
100. Palucka K.A., Taquet N., Sanchez-Chapuis F., Gluckman J.C. Dendritic cells as the terminal stage of monocyte differentiation. J. Immunol. 160(9):1998;4587.
101. Paul S., Laochumroonvorapong P., Kaplan G. Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro. J. Infect. Dis. 174(1):1996;105.
102. Peng X., Kasran A., Ceuppens J.L. Interleukin 12 and B7/CD28 interaction synergistically upregulate interleukin 10 production by human T cells. Cytokine. 9(7):1997;499.
103. Powrie F., Coffman R.L. Inhibition of cell-mediated immunity by IL4 and IL10. Res. Immunol. 144(8):1993;639.
104. Remick D.G., Friedland J.S. Cytokines in Health and Disease. 2nd Review and Expand Edition:1997;Marcel Dekker, New York.
105. Rescigno M. Dendritic cells and the complexity of microbial infection. Trends Microbiol. 10(9):2002;425.
106. Rescigno M., Borrow P. The host-pathogen interaction. new themes from dendritic cell biology Cell. 106(3):2001;267.
107. Rojas M., Barrera L.F., Puzo G., Garcia L.F. Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages. role of nitric oxide and mycobacterial products J. Immunol. 159(3):1997;1352.
108. Rojas M., Olivier M., Gros P., Barrera L.F., Garcia L.F. TNF-alpha and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. J. Immunol. 162(10):1999;6122.
109. Romagnani S. The Th1/Th2 paradigm and allergic disorders. Allergy. 53(46):1998;12.
110. Romagnani S. Th1/Th2 cells. Inflamm. Bowel Dis. 5(4):1999;285.
111. Romagnani S. T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 85(1):2000;9.
112. Romagnani S., Kapsenberg M., Radbruch A., Adorini L. Th1 and Th2 cells. Res. Immunol. 149(9):1998;871.
113. Rook G. Th1- or Th2-cell commitment during infectious disease. an oversimplification? Trends Immunol. 22(9):2001;481.
114. Rosenbrock H.H., Storey C. Mathematics of Dynamical Systems. 1970;Wiley Interscience Division, New York.
115. Russo D.M., Kozlova N., Lakey D.L., Kernodle D. Naive human T cells develop into Th1 effectors after stimulation with Mycobacterium tuberculosis-infected macrophages or recombinant Ag85 proteins. Infect. Immun. 68(12):2000;6826.
116. Sallusto F., Lanzavecchia A. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol. Rev. 177:2000;134.
117. Sallusto F., Lanzavecchia A., Mackay C.R. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today. 19(12):1998;568.
118. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 401(6754):1999;708.
119. Sallusto F., Mackay C.R., Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18:2000;593.
120. Sanchez M.A., Blower S.M. Uncertainty and sensitivity analysis of the basic reproductive rate. Tuberculosis as an example. Am. J. Epidemiol. 145(12):1997;1127.
121. Schwander S.K., Torres M., Sada E., Carranza C., Ramos E., Tary-Lehmann M., Wallis R.S., Sierra J., Rich E.A. Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. J. Infect. Dis. 178(5):1998;1434.
122. Seah G.T., Rook G.A. Il-4 influences apoptosis of mycobacterium-reactive lymphocytes in the presence of TNF-alpha. J. Immunol. 167(3):2001;1230.
123. Serbina N.V., Flynn J.L. Early emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect. Immun. 67(8):1999;3980.
124. Serbina N.V., Flynn J.L. CD8(+) T cells participate in the memory immune response to Mycobacterium tuberculosis. Infect. Immun. 69(7):2001;4320.
125. Sertl K., Takemura T., Tschachler E., Ferrans V.J., Kaliner M.A., Shevach E.M. Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J. Exp. Med. 163(2):1986;436.
126. Silver R.F., Li Q., Ellner J.J. Expression of virulence of Mycobacterium tuberculosis within human monocytes. virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions Infect. Immun. 66(3):1998;1190.
127. Silver R.F., Li Q., Boom W.H., Ellner J.J. Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes. requirement for CD4+T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects J. Immunol. 160(5):1998;2408.
128. Skinner M.A., Yuan S., Prestidge R., Chuk D., Watson J.D., Tan P.L. Immunization with heat-killed Mycobacterium vaccae stimulates CD8+ cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis. Infect. Immun. 65(11):1997;4525.
129. Sornasse T., Larenas P.V., Davis K.A., de Vries J.E., Yssel H. Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J. Exp. Med. 184(2):1996;473.
130. Sprent J., Basten A. Circulating T and B lymphocytes of the mouse. II. Lifespan. Cell Immunol. 7(1):1973;40.
131. Stead W.W., Senner J.W., Reddick W.T., Lofgren J.P. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N. Engl. J. Med. 322(7):1990;422.
132. Stone K.C., Mercer R.R., Gehr P., Stockstill B., Crapo J.D. Allometric relationships of cell numbers and size in the mammalian lung. Am. J. Respir. Cell. Mol. Biol. 6(2):1992;235.
133. Stout R.D., Bottomly K. Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages. J. Immunol. 142(3):1989;760.
134. Sturgill-Koszycki S., Schlesinger P.H., Chakraborty P., Haddix P.L., Collins H.L., Fok A.K., Allen R.D., Gluck S.L., Heuser J., Russell D.G. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science. 263(5147):1994;678.
135. Surcel H.M., Troye-Blomberg M., Paulie S., Andersson G., Moreno C., Pasvol G., Ivanyi J. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology. 81(2):1994;171.
136. Szabo S.J., Dighe A.S., Gubler U., Murphy K.M. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185(5):1997;817.
137. Tan J.S., Canaday D.H., Boom W.H., Balaji K.N., Schwander S.K., Rich E.A. Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens. role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis J. Immunol. 159(1):1997;290.
138. Tascon R.E., Stavropoulos E., Lukacs K.V., Colston M.J. Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon. Infect. Immun. 66(2):1998;830.
139. Tsukaguchi K., Balaji K.N., Boom W.H. CD4+ alpha beta T cell and gamma delta T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production. J. Immunol. 154(4):1995;1786.
140. Tsukaguchi K., de Lange B., Boom W.H. Differential regulation of IFN-gamma, TNF-alpha, and IL-10 production by CD4(+) alphabeta TCR+ T cells and vdelta2(+) gammadelta T cells in response to monocytes infected with Mycobacterium tuberculosis-H37Ra. Cell Immunol. 194(1):1999;12.
141. van Crevel R., Karyadi E., Preyers F., Leenders M., Kullberg B.J., Nelwan R.H., van der Meer J.W. Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J. Infect. Dis. 181(3):2000;1194.
142. van Crevel R., Ottenhoff T.H., van der Meer J.W. Innate immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev. 15(2):2002;294.
143. Van Furth R., Diesselhoff-den Dulk M.C., Mattie H. Quantitative study on the production and kinetics of mononuclear phagocytes during an acute inflammatory reaction. J. Exp. Med. 138(6):1973;1314.
144. van Haarst J.M., de Wit H.J., Drexhage H.A., Hoogsteden H.C. Distribution and immunophenotype of mononuclear phagocytes and dendritic cells in the human lung. Am. J. Respir. Cell. Mol. Biol. 10(5):1994;487.
145. von Andrian U.H., Mackay C.R. T-cell function and migration. Two sides of the same coin. N. Engl. J. Med. 343(14):2000;1020.
146. Wakeham J., Wang J., Magram J., Croitoru K., Harkness R., Dunn P., Zganiacz A., Xing Z. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guerin in IL-12-deficient mice. J. Immunol. 160(12):1998;6101.
147. Westermann J., Pabst R. Distribution of lymphocyte subsets and natural killer cells in the human body. Clin. Invest. 70(7):1992;539.
148. Wigginton J.E., Kirschner D. A model to predict cell-mediated immune regulatory mechanisms during human infection with Mycobacterium tuberculosis. J. Immunol. 166(3):2001;1951.
149. Wilkinson R.J., Patel P., Llewelyn M., Hirsch C.S., Pasvol G., Snounou G., Davidson R.N., Toossi Z. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J. Exp. Med. 189(12):1999;1863.
150. Wilkinson R.J., Llewelyn M., Toossi Z., Patel P., Pasvol G., Lalvani A., Wright D., Latif M., Davidson R.N. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London. a case-control study Lancet. 355(9204):2000;618.
151. Young A.J. The physiology of lymphocyte migration through the single lymph node in vivo. Semin. Immunol. 11(2):1999;73.
152. Young A.J., Hay J. Lymphocyte migration in development and disease. Semin. Immunol. 11(2):1999;71.
153. Yssel H., De Waal Malefyt R., Roncarolo M.G., Abrams J.S., Lahesmaa R., Spits H., de Vries J.E. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J. Immunol. 149(7):1992;2378.
154. Zhang M., Gately M.K., Wang E., Gong J., Wolf S.F., Lu S., Modlin R.L., Barnes P.F. Interleukin 12 at the site of disease in tuberculosis. J. Clin. Invest. 93(4):1994;1733.
155. Zhang M., Lin Y., Iyer D.V., Gong J., Abrams J.S., Barnes P.F. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect. Immun. 63(8):1995;3231.
156. Zhang M., Gong J., Lin Y., Barnes P.F. Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect. Immun. 66(2):1998;794.
157. Zhang M., Gong J., Yang Z., Samten B., Cave M.D., Barnes P.F. Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. J. Infect. Dis. 179(5):1999;1213.
158. Zhu K., Shen Q., Ulrich M., Zheng M. Human monocyte-derived dendritic cells expressing both chemotactic cytokines IL-8, MCP-1, RANTES and their receptors, and their selective migration to these chemokines. Chin. Med. J. (Engl). 113(12):2000;1124.